股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 舒寶國際集團有限公司 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02569 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | III.已發行股 ...

Group 1 - The core announcement is that Mr. Yang Guangwei has submitted his resignation as Co-Company Secretary of Shubao International, effective from November 17, 2025 [1] - The board has appointed Ms. Huang Baolin as the new Co-Company Secretary, also effective from November 17, 2025 [1]

Core Points - Shoubao International (02569) announced that Mr. Yang Guangwei has submitted his resignation as Co-Company Secretary, effective from November 17, 2025 [1] - The Board further announced that Ms. Huang Baolin has been appointed as Co-Company Secretary, effective from November 17, 2025 [1]

Core Viewpoint - Shoubao International (02569.HK) announced the resignation of Yang Guangwei as co-secretary, effective November 17, 2025, and the appointment of Huang Baolin as co-secretary, effective the same date [1] Group 1 - Yang Guangwei has submitted his resignation as co-secretary of the company [1] - Huang Baolin has been appointed as co-secretary and will work alongside Yan Jiawei, the current co-secretary [1]

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本通告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任何部份內容而 產生或因倚賴該等內容而引致的任何損失承擔任何責任。 SOFT INTERNATIONAL GROUP LTD 舒寶國際集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2569） (1) 聯席公司秘書變動; (2) 豁免嚴格遵守上市規則第3.28條及第8.17條 及 (3) 授權代表變動 顏女士的履歷詳情載列於本公司截至2024年12月31日止年度之年報。 1 豁免嚴格遵守上市規則第3.28條及第8.17條 根據聯交所證券上市規則（「上市規則」）第3.28條，發行人必須委任一名公司秘 書，該名人士必須為聯交所認為在學術或專業資格或有關經驗方面足以履行公司 秘書職責的人士。根據上市規則第8.17條，發行人必須委任一名符合上市規則第 3.28條規定的公司秘書。 儘管顏女士並不具備上市規則第3.28及8.17條所規定的資格，鑒於顏女士的背景 及經驗，董事認為其有能力履行聯席公司秘書的職務。聯交所就委任顏女士為其 中一名聯席公司秘書而向本 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 舒寶國際集團有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02569 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | 本月底法定/註冊 ...

Investment Plans - The company plans to utilize HKD 24,860,000 for the purchase of machinery to establish a baby care and women's care product production line by December 31, 2026[3]. - An investment of HKD 22,136,000 is allocated for machinery to set up a non-woven fabric production line, expected to be utilized by December 31, 2026[3]. - The company intends to enhance its brand, marketing, and promotional activities with an investment of HKD 14,558,000, to be utilized by December 31, 2026[3]. - An investment of HKD 15,069,000 is planned for upgrading the company's warehouse and IT infrastructure, expected to be utilized by December 31, 2026[3]. - The company has allocated HKD 8,514,000 for general working capital, to be utilized by December 31, 2026[3]. - The total expected utilization of unutilized listing proceeds amounts to HKD 85,137,000[3]. Corporate Governance - The company emphasizes that the additional information provided should be read in conjunction with the 2024 annual report, which remains unchanged[4]. - The chairman and executive director of the company is Yan Peikun, with a team of executive and non-executive directors listed[5].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 舒寶國際集團有限公司 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02569 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | 本月底法定/註冊股 ...

Revenue and Profit Growth - For the six months ended June 30, 2025, the group's revenue increased by approximately RMB 109.6 million or 33.2% to approximately RMB 439.3 million compared to the previous period's revenue of approximately RMB 329.7 million[10]. - Profit for the same period rose by approximately RMB 5.7 million or 23.0% to approximately RMB 30.5 million, up from approximately RMB 24.8 million in the previous period[10]. - Revenue increased by approximately RMB 109.6 million or 33.2% to approximately RMB 439.3 million from the previous period's RMB 329.7 million[16]. - Gross profit increased by approximately RMB 41.6 million or 39.4% to approximately RMB 147.2 million, with gross margin rising from about 32.0% to approximately 33.5%[18]. - Net profit for the six months ended June 30, 2025, was RMB 30,535,000, an increase of 23.4% compared to RMB 24,763,000 in 2024[62]. - For the six months ended June 30, 2025, total revenue reached RMB 439,316,000, a 33.2% increase from RMB 329,678,000 in the same period of 2024[81]. Segment Performance - The contract manufacturing business accounted for approximately 60.3% of total revenue, while the branded products business contributed approximately 28.5%[11]. - Revenue from the contract manufacturing segment increased by approximately RMB 80.4 million or 43.6% to approximately RMB 264.8 million, driven by increased demand in the Russian market[11]. - The branded products segment achieved revenue growth of approximately RMB 19.5 million or 18.4%, reaching approximately RMB 125.4 million compared to approximately RMB 105.9 million in the previous period[12]. - Contract manufacturing revenue increased from approximately RMB 184.4 million to approximately RMB 264.8 million, with sales to the top Russian client rising by approximately RMB 74.9 million to approximately RMB 189.3 million[17]. - Brand product revenue grew from approximately RMB 105.9 million to approximately RMB 125.4 million, an increase of about 18.4% due to online sales and the successful launch of a new women's care brand product[17]. Expenses and Costs - Sales cost rose by approximately RMB 68.0 million or 30.3% to approximately RMB 292.1 million, driven by direct material costs increasing from approximately RMB 191.7 million to approximately RMB 256.9 million, a rise of about 34.0%[16]. - Selling and distribution expenses rose by approximately RMB 36.7 million or 76.6% to approximately RMB 84.6 million, primarily due to increased online sales and promotional expenses[19]. - Administrative and other operating expenses increased by approximately RMB 4.6 million or 23.4% to approximately RMB 24.3 million, mainly due to a significant rise in consulting fees[22]. Cash Flow and Financial Position - As of June 30, 2025, the company's bank balances and cash amounted to approximately RMB 165.4 million, a significant increase from RMB 26.7 million as of December 31, 2024[32]. - The total interest-bearing borrowings increased to approximately RMB 75.0 million as of June 30, 2025, compared to RMB 33.0 million as of December 31, 2024, resulting in a capital debt ratio of 15.7%[32]. - Trade and other receivables decreased by approximately RMB 16.0 million or 8.1% to approximately RMB 182.3 million, with trade receivables decreasing by approximately RMB 37.6 million or 25.7%[28]. - The company reported a net cash increase of RMB 138,820,000 in cash and cash equivalents by the end of the reporting period, compared to a decrease of RMB 46,783,000 in the previous year[72]. - Operating cash flow for the six months ended June 30, 2025, was RMB 81,393,000, a significant improvement from a cash outflow of RMB 35,385,000 in 2024[72]. Corporate Governance and Compliance - The company has established an audit committee in compliance with corporate governance codes, ensuring financial oversight[60]. - The company plans to continue reviewing and monitoring corporate governance practices to align with the latest developments in corporate governance[60]. - The company has adhered to relevant laws and regulations without any significant violations during the reporting period[56]. - The company emphasizes accountability and transparency in its corporate governance principles[58]. Shareholder Information - Mr. Yan holds 675,000,000 shares, representing 67.50% of the company's issued share capital[45]. - Softo BVI, owned by Mr. Yan, holds 442,125,000 shares, approximately 44.21% of the issued share capital[49]. - Wish BVI and Galaxey BVI, both subsidiaries of Softo BVI, hold 120,000,000 shares (12.00%) and 112,875,000 shares (11.29%) respectively[49]. - Mr. Zeng holds 75,000,000 shares, representing 7.50% of the company's issued share capital[47]. - Aspiring BVI and Ambition BVI, owned by Mr. Zeng, hold 45,400,000 shares (4.54%) and 29,600,000 shares (2.96%) respectively[49]. Investment and Capital Expenditure - The company has no significant investments, acquisitions, or disposals of subsidiaries during the period[40]. - The company has a capital expenditure commitment of RMB 14,670,000 as of June 30, 2025, down from RMB 20,972,000 at the end of 2024[130]. - The company acquired property, plant, and equipment amounting to approximately RMB 22,609,000 for the six months ended June 30, 2025, compared to RMB 14,100,000 for the same period in 2024[96]. Research and Development - Research and development expenses were RMB 11,871,000, slightly up from RMB 11,704,000 in the previous year[88]. - The company incurred research and development costs during the six months ended June 30, 2025, amounting to RMB 13,974,000, compared to RMB 13,427,000 for the same period in 2024[91].

Core Viewpoint - The Hong Kong IPO market is active, with 57 new listings and a total fundraising amount of 131.9 billion HKD as of August 25. However, many companies face challenges in meeting both domestic and Hong Kong regulatory requirements for listing [1]. Group 1: Hong Kong IPO Overview - As of August 25, 2023, there have been 57 new IPOs on the Hong Kong Stock Exchange, raising a total of 131.9 billion HKD [1]. - There are currently 211 companies that have submitted applications for listing in Hong Kong [1]. Group 2: Listing Challenges - Companies looking to list in Hong Kong must comply with both domestic laws and Hong Kong's regulatory framework, making the IPO preparation process complex and demanding [1]. Group 3: Resources for Companies - A compilation of Hong Kong listing rules and disclosure documents for domestic companies planning to list in Hong Kong has been organized to assist businesses in understanding the latest regulatory dynamics [1].